[미국특허]
Methods and systems for providing gender specific pharmaceuticals
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
B65D-001/09
A61F-002/38
A61F-002/00
A61F-002/82
A61B-090/92
A61B-090/94
A61J-001/03
A61J-001/18
A61B-017/06
A61B-017/80
A61B-017/86
A61F-002/30
A61F-002/32
A61F-002/40
A61F-002/42
A61F-002/44
A61F-002/46
A61F-002/28
A61F-002/48
출원번호
US-0071965
(2016-03-16)
등록번호
US-9750612
(2017-09-05)
발명자
/ 주소
Bonutti, Peter M.
출원인 / 주소
P Tech, LLC
인용정보
피인용 횟수 :
0인용 특허 :
71
초록▼
The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes at least one male dosage having a first dosage amount, an in
The present disclosure provides a system of gender specific pharmaceuticals. The system includes a first package of a pharmaceutical for use by a male and a second package of a pharmaceutical for use by a female. The first package includes at least one male dosage having a first dosage amount, an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage, and a male label coupled to the first package, the label including a male gender specifier. The female package includes at least one female dosage having a second dosage amount that is smaller than the first dosage amount, an insert positioned in the first package, the insert including a recommended male dosage and a recommended female dosage that is different than the male dosage, and a female label coupled to the second package, the female label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier.
대표청구항▼
1. A method for providing gender specific pharmaceuticals, the method comprising: providing a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:at least one male dosage having a first do
1. A method for providing gender specific pharmaceuticals, the method comprising: providing a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:at least one male dosage having a first dosage amount;a first insert positioned in the first package, the first insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; anda first label coupled to the first package, wherein at least one of the provided first label and first package includes a male gender specifier; andproviding a second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:at least one female dosage having a second dosage amount, wherein the first dosage amount is larger than the second dosage amount;a second insert positioned in the second package, the second insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; anda second label coupled to the second package, wherein at least one of the provided second label and second package includes a female gender specifier, wherein the female gender specifier is different than the male gender specifier. 2. The method of claim 1, wherein at least a portion of the female dosage includes a gender specifier. 3. The method of claim 2, wherein the gender specifier is a pink color that covers at least a portion of the female dosage. 4. The method of claim 1, wherein the at least one male dosage and the at least one female dosage is at least one of an oral medication and an intravenous medication. 5. The method of claim 4, wherein the at least one male dosage and the at least one female dosage is at least one of a tablet, capsule, powder, and liquid. 6. The method of claim 1, wherein at least a portion of the first package includes a gender specifier. 7. The method of claim 6, wherein the gender specifier is a color that is at least one of blue and green. 8. The method of claim 1, wherein least a portion of the second package includes a gender specifier. 9. The method of claim 8, wherein the gender specifier is a color that is at least one of pink and purple. 10. The method of claim 1, wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color. 11. The method of claim 1, wherein at least one of the first insert and the second insert further comprises a recommended male dosage and a recommended female dosage that is different than the male dosage regardless of weight or body mass index. 12. The method of claim 1, wherein at least one of the first and second packages includes an RFID label. 13. A system of gender specific pharmaceuticals, the system comprising: a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:at least one male dosage having a first dosage amount;a first insert positioned in the first package, the first insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; anda first label coupled to the first package, wherein at least one of the provided first label and first package includes a male gender specifier; anda second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:at least one female dosage having a second dosage amount that is smaller than the first dosage amount;a second insert positioned in the second package, the second insert including a recommended male dosage and a recommended female dosage that is different than the male dosage; anda second label coupled to the second package, wherein at least one of the provided second label and second package includes a female gender specifier, wherein the female gender specifier is different than the male gender specifier. 14. The system of claim 13, wherein at least a portion of the female dosage includes a gender specifier. 15. The system of claim 14, wherein the gender specifier is a pink color that covers at least a portion of the female dosage. 16. The system of claim 13, wherein the at least one male dosage and the at least one female dosage is at least one of an oral medication and an intravenous medication. 17. The system of claim 16, wherein the at least one male dosage and the at least one female dosage is at least one of a tablet, capsule, powder, and liquid. 18. The system of claim 13, wherein at least a portion of the first package includes a gender specifier. 19. The system of claim 18, wherein the gender specifier is a color that is at least one of blue and green. 20. The system of claim 13, wherein least a portion of the second package includes a gender specifier. 21. The system of claim 20, wherein the gender specifier is a color that is at least one of pink and purple. 22. The system of claim 13, wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color. 23. The system of claim 13, wherein at least one of the first and second packages includes an RFID label. 24. The system of claim 13, wherein at least one of the first insert and the second insert further comprises a recommended male dosage and a recommended female dosage that is different than the male dosage regardless of weight or body mass index. 25. A method for providing gender specific pharmaceuticals, the method comprising: providing a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:at least one male dosage having a first dosage amount; anda first label coupled to the first package, the label including a male gender specifier; and providing a second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:at least one female dosage having a second dosage amount that is different than the first dosage amount; anda second label coupled to the second package, the second label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier. 26. The method of claim 25, wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color. 27. The method of claim 25, wherein at least a portion of the female dosage includes a gender specifier that is a pink color covering at least a portion of the female dosage. 28. A system of gender specific pharmaceuticals, the system comprising: a first package comprising a pharmaceutical for use by a male, wherein the pharmaceutical comprises a central nervous system depressant, the first package comprising:at least one male dosage having a first dosage amount; anda first label coupled to the first package, the label including a male gender specifier; anda second package comprising a pharmaceutical for use by a female, wherein the pharmaceutical comprises a central nervous system depressant, the second package comprising:at least one female dosage having a second dosage amount that is different than the first dosage amount; anda second label coupled to the second package, the second label including a female gender specifier, wherein the female gender specifier is different than the male gender specifier. 29. The system of claim 28, wherein at least a portion of the first package includes a male gender specifier that is at least one of blue and green color and wherein at least a portion of the second package includes a female gender specifier that is at least one of pink and purple color. 30. The system of claim 28, wherein at least one of the first and second packages includes an insert having a recommended male dosage and a recommended female dosage that is different than the male dosage regardless of weight or body mass index.
McNulty Donald E. (Warsaw IN) Kelman David C. (Winona Lake IN) Moreland John R. (Pacific Palisades CA) Hamm John E. (Warsaw IN), Alignment guide for a bone cutting block.
Gerard A. Ateshian ; Van C. Mow ; Robert J. Pawluk ; Melvin P. Rosenwasser, Anatomically correct prosthesis and method and apparatus for manufacturing prosthesis.
Jones, Nolan C.; VanDiepenbos, Jeffery A.; Habegger, Abraham P.; Earl, Brian D., Femoral prosthesis system having provisional component with visual indicators.
Tsougarakis, Konstantinos; Steines, Daniel; Timsari, Bijan, Fusion of multiple imaging planes for isotropic imaging in MRI and quantitative image analysis using isotropic or near-isotropic imaging.
McNulty Donald E. (Warsaw IN) Kelman David C. (Winona Lake IN) Moreland John R. (Pacific Palisades CA) Hamm John E. (Warsaw IN), Method for installing a femoral component.
Walker Peter S. (15 Hallette Hill Rd. Weston MA 02193) Ewald Frederick C. (4 Black Oak Rd. Weston MA 02193), Method of design of human joint prosthesis.
Tsougarakis, Konstantinos; Steines, Daniel; Vissa, Bhaskar Rao; Lang, Philipp; Linder, Barry J., Methods for determining meniscal size and shape and for devising treatment.
Tsougarakis, Konstantinos; Steines, Daniel; Vissa, Bhaskar Rao; Lang, Philipp; Linder, Barry J., Methods for determining meniscal size and shape and for devising treatment.
Tornier,Alain; Sirveaux,Francois; Walch,Gilles; Mole,Daniel; Levigne,Christophe; Boileau,Pascal; Favard,Luc, Set of humeral components for total shoulder prosthesis.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.